Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 2'-Deoxyuridine | 951-78-0 | 100.0% | 10 MM 1 ML
SDP

Catalog No. 5000409924
Encompass_Preferred

2'-Deoxyuridine is a brain-penetrant pyrimidines nucleotide associated with nervous system diseases. It can increase chromosome breakage and decrease thymidylate synthetase activity. It serves as a precursor in the synthesis of Edoxudine and is an analogue of 5-ethynyl-2'-deoxyuridine. Additionally, 2'-deoxyuridine reduces microglial activation and improves oxidative stress damage by modulating glycolytic metabolism on Aβ25-35-induced brain injury, showing promise for Alzheimer's disease (AD) research.

  • Brain-penetrant pyrimidines nucleotide associated with nervous system diseases.
  • Increases chromosome breakage.
  • Decreases thymidylate synthetase activity.
  • Reduces microglial activation.
  • Improves oxidative stress damage by modulating glycolytic metabolism on Aβ25-35-induced brain injury.
  • Promising for Alzheimer's disease (AD) research.

Catalog No. 50-004-09924 Supplier Medchemexpress LLC Supplier No. HYD018610MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

2'-Deoxyuridine is a brain-penetrant pyrimidines nucleotide associated with nervous system diseases. It can increase chromosome breakage and decrease thymidylate synthetase activity. It serves as a precursor in the synthesis of Edoxudine and is an analogue of 5-ethynyl-2'-deoxyuridine. Additionally, 2'-deoxyuridine reduces microglial activation and improves oxidative stress damage by modulating glycolytic metabolism on Aβ25-35-induced brain injury, showing promise for Alzheimer's disease (AD) research.

  • Brain-penetrant pyrimidines nucleotide associated with nervous system diseases.
  • Increases chromosome breakage.
  • Decreases thymidylate synthetase activity.
  • Reduces microglial activation.
  • Improves oxidative stress damage by modulating glycolytic metabolism on Aβ25-35-induced brain injury.
  • Promising for Alzheimer's disease (AD) research.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.